GGrantIndex
Sort

24,827 grants matching epilepsy

MONEAD Data and Statistical Center

$680,451
Nancy Browning · The Emmes Company, Llc · U01 · FY2013 · NS

Electrophysiological representations of odor in the human brain

$680,384
Christina Maria Zelano · Northwestern University At Chicago · R01 · FY2024 · DC

Retraining and Control Therapy (ReACT): Sense of control and catastrophic symptom expectations as targets of a cognitive behavioral treatment for pediatric psychogenic non-epileptic seizures (PNES)

$680,257
Aaron D Fobian · University Of Alabama At Birmingham · R33 · FY2024 · MH

Disrupted ciliary signaling in the brain pathology of Tuberous Sclerosis Complex

$680,232
Mustafa None Sahin · Boston Children'S Hospital · R01 · FY2021 · NS

Megalencephaly and segmental brain overgrowth in humans

$680,186
William B Dobyns · Seattle Children'S Hospital · R01 · FY2015 · NS

Using brain lesions and deep brain stimulation to identify an epilepsy circuit

$680,078
Michael D Fox · Brigham And Women'S Hospital · R01 · FY2022 · NS

Disrupted Ciliary Signaling in the Brain Pathology of Tuberous Sclerosis Complex

$680,023
Mustafa None Sahin · Boston Children'S Hospital · R01 · FY2022 · NS

Cell Identity Determination In Human Brain: Somatic Mutation and Cell Lineage

$680,000
Christopher A Walsh · Boston Children'S Hospital · R01 · FY2023 · NS

Optimizing sleep spindle measurements as translational assays of memory consolidation

$679,933
Dara S Manoach · Massachusetts General Hospital · UH3 · FY2023 · MH

High Performance Seizure Monitoring and Alert System

$679,605
Deng-Shan Shiau · Optima Neuroscience, Inc. · R44 · FY2015 · NS

Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders

$679,492
Michael Bozik · Knopp Biosciences, Llc · U44 · FY2019 · NS

Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits

$679,487
Thota Ganesh · Emory University · UH3 · FY2023 · NS

National study of antiepileptic use among patients with dementia in long-term care

$679,475
Lauren Beth Gerlach · University Of Michigan At Ann Arbor · R01 · FY2025 · AG

Fostering medication adherence in children with epilepsy using mHealth technology

$679,289
Avani C Modi · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · NR

AAV Gene Therapy for Sialidosis: from Mice to IND

$679,207
Heather L Gray-Edwards · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · NS

Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidity

$678,736
Kurt Francis Hauser · Virginia Commonwealth University · R01 · FY2022 · DA

Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidity

$678,736
Kurt Francis Hauser · Virginia Commonwealth University · R01 · FY2024 · DA

Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidity

$678,736
Kurt Francis Hauser · Virginia Commonwealth University · R01 · FY2025 · DA

Innovative therapeutic approaches to address excitotoxic CNS/neuronal damage in opioid-neuroHIV comorbidity

$678,736
Kurt Francis Hauser · Virginia Commonwealth University · R01 · FY2023 · DA

EEG Biomarkers Derived from Dynamical Network Models Enable Rapid Paths to Accurate Diagnosis and Effective Treatment of Epilepsy

$678,609
Sridevi V. Sarma · Johns Hopkins University · R35 · FY2024 · NS

Lipid Nutrition and the Brain

$678,238
Stanley I Rapoport · National Institute On Aging · ZIA · FY2011 · AG

Spatiotemporal dynamics of the human emotion network

$678,137
Edward Chang · University Of California, San Francisco · R01 · FY2021 · MH

Epigenetic Regulation of Ube3a as a Treatment for Angelman Syndrome

$678,041
Benjamin D Philpot · Univ Of North Carolina Chapel Hill · R01 · FY2013 · MH

ACC: Callosal Agenesis as a Window into Common Neurodevelopmental Disorders

$677,869
Elliott Sherr · University Of California, San Francisco · R01 · FY2017 · NS

NS-PEACE Neonatal Seizures -Predicting Epilepsy and Assessing Comparative Effectiveness

$677,582
Zachary Michael Grinspan · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS